Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208162883> ?p ?o ?g. }
- W3208162883 endingPage "1429" @default.
- W3208162883 startingPage "1429" @default.
- W3208162883 abstract "Methods to improve drug delivery efficiency through blood-brain barrier disruption (BBBD) based on microbubbles and focused ultrasound (FUS) are continuously being studied. However, most studies are being conducted in preclinical trial environments using small animals. The use of the human skull shows differences between the clinical and preclinical trials. BBBD results from preclinical trials are difficult to represent in clinical trials because various distortions of ultrasound by the human skull are excluded in the former. Therefore, in our study, a clinical validation platform based on a preclinical trial environment, using a human skull fragment and a rat model, was developed to induce BBBD under conditions similar to clinical trials. For this, a human skull fragment was inserted between the rat head and a 250 kHz FUS transducer, and optimal ultrasound parameters for the free field (without human skull fragment) and human skull (with human skull fragment) were derived by 300 mVpp and 700 mVpp, respectively. BBBD was analyzed according to each case using magnetic resonance images, Evans blue dye, cavitation, and histology. Although it was confirmed using magnetic resonance images and Evans blue dye that a BBB opening was induced in each case, multiple BBB openings were observed in the brain tissues. This phenomenon was analyzed by numerical simulation, and it was confirmed to be due to standing waves owing to the small skull size of the rat model. The stable cavitation doses (SCDh and SCDu) in the human skull decreased by 13.6- and 5.3-fold, respectively, compared to those in the free field. Additionally, the inertial cavitation dose in the human skull decreased by 1.05-fold compared to that of the free field. For the histological analysis, although some extravasated red blood cells were observed in each case, it was evaluated as recoverable based on our previous study results. Therefore, our proposed platform can help deduct optimal ultrasound parameters and BBBD results for clinical trials in the preclinical trials with small animals because it considers variables relevant to the human skull." @default.
- W3208162883 created "2021-11-08" @default.
- W3208162883 creator A5023165018 @default.
- W3208162883 creator A5030511139 @default.
- W3208162883 creator A5033065675 @default.
- W3208162883 creator A5036127600 @default.
- W3208162883 creator A5047248807 @default.
- W3208162883 creator A5054320294 @default.
- W3208162883 creator A5065064661 @default.
- W3208162883 creator A5069512218 @default.
- W3208162883 creator A5070633285 @default.
- W3208162883 date "2021-10-28" @default.
- W3208162883 modified "2023-09-25" @default.
- W3208162883 title "Verification of Blood-Brain Barrier Disruption Based on the Clinical Validation Platform Using a Rat Model with Human Skull" @default.
- W3208162883 cites W1409374736 @default.
- W3208162883 cites W1692343830 @default.
- W3208162883 cites W1894852965 @default.
- W3208162883 cites W1970910247 @default.
- W3208162883 cites W1971119618 @default.
- W3208162883 cites W1979515779 @default.
- W3208162883 cites W1979872711 @default.
- W3208162883 cites W1988950556 @default.
- W3208162883 cites W1996478078 @default.
- W3208162883 cites W2017741298 @default.
- W3208162883 cites W2026210347 @default.
- W3208162883 cites W2058276045 @default.
- W3208162883 cites W2076320457 @default.
- W3208162883 cites W2084895299 @default.
- W3208162883 cites W2093245095 @default.
- W3208162883 cites W2115362657 @default.
- W3208162883 cites W2127980347 @default.
- W3208162883 cites W2164322384 @default.
- W3208162883 cites W2166980283 @default.
- W3208162883 cites W2169057357 @default.
- W3208162883 cites W2322473773 @default.
- W3208162883 cites W2433010802 @default.
- W3208162883 cites W2462521067 @default.
- W3208162883 cites W2462582760 @default.
- W3208162883 cites W2476585130 @default.
- W3208162883 cites W2512281096 @default.
- W3208162883 cites W2519325617 @default.
- W3208162883 cites W2552822432 @default.
- W3208162883 cites W2569559526 @default.
- W3208162883 cites W2575986641 @default.
- W3208162883 cites W2604367361 @default.
- W3208162883 cites W2730613845 @default.
- W3208162883 cites W2744282323 @default.
- W3208162883 cites W2773233791 @default.
- W3208162883 cites W2789387294 @default.
- W3208162883 cites W2790852710 @default.
- W3208162883 cites W2887165190 @default.
- W3208162883 cites W2904129609 @default.
- W3208162883 cites W2912345775 @default.
- W3208162883 cites W2919809987 @default.
- W3208162883 cites W2970204123 @default.
- W3208162883 cites W2977590864 @default.
- W3208162883 cites W2981777948 @default.
- W3208162883 cites W2982221479 @default.
- W3208162883 cites W2987250823 @default.
- W3208162883 cites W3034784818 @default.
- W3208162883 cites W3091765790 @default.
- W3208162883 cites W3094736709 @default.
- W3208162883 cites W3106366470 @default.
- W3208162883 cites W3120769833 @default.
- W3208162883 cites W3127037572 @default.
- W3208162883 cites W3185726729 @default.
- W3208162883 cites W3102837745 @default.
- W3208162883 doi "https://doi.org/10.3390/brainsci11111429" @default.
- W3208162883 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8615862" @default.
- W3208162883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34827428" @default.
- W3208162883 hasPublicationYear "2021" @default.
- W3208162883 type Work @default.
- W3208162883 sameAs 3208162883 @default.
- W3208162883 citedByCount "2" @default.
- W3208162883 countsByYear W32081628832022 @default.
- W3208162883 crossrefType "journal-article" @default.
- W3208162883 hasAuthorship W3208162883A5023165018 @default.
- W3208162883 hasAuthorship W3208162883A5030511139 @default.
- W3208162883 hasAuthorship W3208162883A5033065675 @default.
- W3208162883 hasAuthorship W3208162883A5036127600 @default.
- W3208162883 hasAuthorship W3208162883A5047248807 @default.
- W3208162883 hasAuthorship W3208162883A5054320294 @default.
- W3208162883 hasAuthorship W3208162883A5065064661 @default.
- W3208162883 hasAuthorship W3208162883A5069512218 @default.
- W3208162883 hasAuthorship W3208162883A5070633285 @default.
- W3208162883 hasBestOaLocation W32081628831 @default.
- W3208162883 hasConcept C105702510 @default.
- W3208162883 hasConcept C118552586 @default.
- W3208162883 hasConcept C125287762 @default.
- W3208162883 hasConcept C126322002 @default.
- W3208162883 hasConcept C126838900 @default.
- W3208162883 hasConcept C136229726 @default.
- W3208162883 hasConcept C142724271 @default.
- W3208162883 hasConcept C143409427 @default.
- W3208162883 hasConcept C143753070 @default.
- W3208162883 hasConcept C159985019 @default.
- W3208162883 hasConcept C192562407 @default.
- W3208162883 hasConcept C2776905153 @default.